SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MEDX ... anybody following?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2240 62 0 MEDX
Emcee:  Ed Offstein Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1765Thanks Erik - for the info on Celldex and all your many postings here. That putA.J. Mullen-6/19/2007
1764Ok guys. How about a Danish language lesson? <i> Biotekselskabet Genmab eIcebrg-6/19/2007
1763Most probably a belated reaction to the Humax-CD20 results in RA, which were notIcebrg-6/19/2007
1762Genmab was down 3.7% on 5x's avg volume in Europe today. No news that I coutom r. phillips-6/19/2007
1761Medarex' share of the equity is still 60 %. In the most recent 10-K, the comIcebrg-6/19/2007
1760Any idea how much of Celldex is still owned by Medarex? This was from Celldex&#A.J. Mullen-6/19/2007
1759Edging forward in brain cancer By Urooj Mujtaba Staff Writer [BioCentury] GliobIcebrg-6/19/2007
1758We have had two insider transactions (sort of). Lerner and Schaller (director) hIcebrg-6/18/2007
1757re. HuMax-CD20 (Genmab): UPDATE 3-Glaxo aims to launch five cancer drugs by 201tom r. phillips-6/18/2007
1756Genmab Announces Development Plans for Ofatumumab Monday June 18, 8:49 am ET Sumnigel bates-6/18/2007
1755UPREGULATION OF PD-1 EXPRESSION ON CIRCULATING AND INTRAHEPATIC HCV-SPECIFIC CD8Icebrg-6/16/2007
1754Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid Arthritis StIcebrg-6/15/2007
1753Genmab Initiates Ofatumumab Front Line NHL Study Thursday June 14, 5:01 pm ET SuIcebrg-6/14/2007
1752Role Of GM-CSF In The Immune Response To Tumors The role of granulocyte-macrophIcebrg-6/13/2007
1751GSK reveals details of $2bn antibody By Mike Nagle 12/06/2007 - GlaxoSmithKlinIcebrg-6/13/2007
1750Morgan Stanley on PFE tici [Unverified copying from the Yahoo MEDX board] WhilIcebrg-6/9/2007
1749Cramer - Medarex - off with its head! Personal Finance: Jim Cramer's Lighttom pope-6/9/2007
1748Melanoma Therapy From Medarex May Be Next Big Thing Investor's Business DailIcebrg-6/9/2007
1747I don't think Morgan Stanley is exactly right. Seems like the sentence is pkenhott-6/7/2007
1746IDM Pharma Presents Preliminary Results from Phase II UVIDEM(R) Melanoma VaccineIcebrg-6/7/2007
1745Celldex Therapeutics Presents Data from Phase 1 Study of CDX-1307 Immunotherapy Icebrg-6/7/2007
1744From MEDX's 10-K: "The study is designed to assess best objective respgcrispin-6/7/2007
1743Didn't want you to have 13 posts in a row. Bad luck and all that. edit: Okenhott-6/6/2007
1742[Some more text attributed to Morgan Stanley's comment after Medarex ASCO daIcebrg-6/6/2007
1741Posting on Yahoo attributed to Morgan Stanley (non-verified). Conclusion: UpdaIcebrg-6/6/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News